Besremi Injection
Product Images NDC 73536-500

68 FDA label images from Pharmaessentia Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 68 technical images submitted to the FDA as part of the official labeling for Besremi (NDC 73536-500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmaessentia Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Besremi Figure A (Besremi 01)

Besremi Figure A (Besremi 01)
An instructional diagram of the BESREMi Pen injection device showing its parts. Labels identify the syringe cap, textured collar, dose lines, syringe body, gray stopper, finger flange, and plunger on the syringe. The needle assembly is shown separately with clear needle cap, pink needle shield, and needle.*
FDA Label Image

Besremi Figure B (Besremi 02)

Besremi Figure B (Besremi 02)
An instructional diagram showing the BESREMi Pen carton stored inside a refrigerator compartment. The image includes the BESREMi carton on the left and a refrigerator interior on the right, indicating proper cool storage of the product.*
FDA Label Image

Besremi Figure C And D (Besremi 03)

Besremi Figure C And D (Besremi 03)
An instructional diagram showing how to adjust the medicine level on a BESREMi Pen syringe for a prescribed dose. It highlights aligning the top outer edge of the gray stopper with the dose line on the syringe, illustrated with examples for a 350 mcg dose. The diagram advises against measuring from the dome at the top of the stopper, using clear labels and arrows to guide proper dose setting.*
FDA Label Image

Besremi Figure E (Besremi 04)

Besremi Figure E (Besremi 04)
An illustration showing the BESREMi Pen injection packaging alongside a detailed diagram of the pen device's internal cartridge and dosing mechanism. The image highlights how the medication cartridge is contained within the pen for subcutaneous injection.*
FDA Label Image

Besremi Figure F (Besremi 05)

Besremi Figure F (Besremi 05)
An illustration labeled Figure F showing the packaging of BESREMi Pen, an injectable solution of ROPEGINTERFERON ALFA-2B. The image highlights the location of the expiration date on the box, indicated as 'EXP: YYYY-MM,' along with a visible barcode and other package details.*
FDA Label Image

Besremi Figure G (Besremi 06)

Besremi Figure G (Besremi 06)
Illustration showing a BESREMi Pen box on a surface next to a timer displaying a countdown labeled 15-30 minutes, likely indicating a preparation or usage time related to the product.*
FDA Label Image

Besremi Figure H (Besremi 07)

Besremi Figure H (Besremi 07)
Instructional illustration labeled as Figure H showing a single square or rectangular pad or patch with the text 'ROUTING' on it, possibly related to the BESREMi Pen injection device or its administration process. The image shows the pad's front view with a blank section above the text.*
FDA Label Image

Besremi Figure I (Besremi 08)

Besremi Figure I (Besremi 08)
An illustration of a sharps disposal container designed for safe disposal of used needles and syringes. The container is rectangular with a white lid and red body, featuring a label on the side for identification.*
FDA Label Image

Besremi Figure J (Besremi 09)

Besremi Figure J (Besremi 09)
An instructional illustration labeled Figure J showing a paper towel dispenser with the paper towel directed toward a sink and a trash can labeled TRASH positioned nearby, suggesting proper disposal of used materials during injection preparation or administration.*
FDA Label Image

Besremi Figure K (Besremi 10)

Besremi Figure K (Besremi 10)
An instructional illustration showing a single-use alcohol prep pad and a small cotton ball placed on top of a beige-colored strip, possibly a bandage or adhesive tape, used in a medical or injection-related context.*
FDA Label Image

Besremi Figure L (Besremi 11)

Besremi Figure L (Besremi 11)
An instructional illustration labeled "Figure L" showing hands removing or handling a protective cover on the top of a vial or cartridge, likely demonstrating part of the preparation process for injection.*
FDA Label Image

Besremi Figure M (Besremi 12)

Besremi Figure M (Besremi 12)
An instructional illustration showing the BESREMi Pen injection packaging with an arrow indicating the opening of the outer carton to reveal the pen device inside a clear plastic tray. The figure is labeled as 'Figure M.'*
FDA Label Image

Besremi Figure N (Besremi 13)

Besremi Figure N (Besremi 13)
An instructional diagram showing a hand removing a prefilled BESREMi Pen injector from its plastic packaging tray. The image highlights the pen syringe with visible label information and a cap at the end opposite the needle assembly.*
FDA Label Image

Besremi Figure O (Besremi 14)

Besremi Figure O (Besremi 14)
An instructional illustration showing a close-up of an eye observing a dose indicator on an injection pen. The pen is marked with dose levels in micrograms up to 900 and features a plunger and black dose cap at the top. This likely relates to the use or dosing of the BESREMi Pen injection device by PharmaEssentia USA.*
FDA Label Image

Besremi Figure P (Besremi 15)

Besremi Figure P (Besremi 15)
An instructional illustration showing a hand peeling off the backing from a medical device, with an arrow pointing to the device after the backing is removed, indicating preparation for use. The figure is labeled 'Figure P.'*
FDA Label Image

Besremi Figure Q (Besremi 16)

Besremi Figure Q (Besremi 16)
An instructional illustration showing two hands preparing a syringe. The top hand is holding and rotating a black cap or component, while the bottom hand holds the syringe vertically. The image is labeled 'Figure Q'.*
FDA Label Image

Besremi Figure R (Besremi 17)

Besremi Figure R (Besremi 17)
An instructional illustration showing hands removing a cap from a syringe needle by twisting and pulling upward. The image is labeled as Figure R and demonstrates the step of preparing an injection for the BESREMi Pen injection solution, 500 ug/.5mL or 500 ug/mL.*
FDA Label Image

Besremi Figure S (Besremi 18)

Besremi Figure S (Besremi 18)
An instructional illustration labeled Figure S, depicting a syringe attached to a pen-like injection device, likely demonstrating use or assembly for a subcutaneous injection.*
FDA Label Image

Besremi Figure T (Besremi 19)

Besremi Figure T (Besremi 19)
An anatomical illustration showing recommended subcutaneous injection sites for BESREMi Pen (Ropeginterferon Alfa-2b). Highlighted areas include the abdomen below the navel, the sides of the upper thighs, and around the lower back/hip region.*
FDA Label Image

Besremi Figure U (Besremi 20)

Besremi Figure U (Besremi 20)
An instructional illustration showing a hand cleaning the skin surface with a cotton pad or swab prior to injection, as part of subcutaneous injection preparation for the BESREMi Pen (ROPEGINTERFERON ALFA-2B). The figure is labeled as Figure U.*
FDA Label Image

Besremi Figure V (Besremi 21)

Besremi Figure V (Besremi 21)
Instructional illustration showing the proper technique for using the BESREMi Pen injection device. The image depicts a hand holding the pen and another hand performing an action, likely related to preparing or administering a subcutaneous injection.*
FDA Label Image

Besremi Figure W (Besremi 22)

Besremi Figure W (Besremi 22)
An instructional illustration showing a hand holding a syringe with the other hand removing a needle cap by pulling it straight off. The image indicates proper needle uncapping technique for injection preparation.*
FDA Label Image

Besremi Figure X (Besremi 23)

Besremi Figure X (Besremi 23)
An instructional illustration showing a hand pressing the plunger of a prefilled pen injector syringe, likely demonstrating the procedure to administer a subcutaneous injection. The pen injector appears to be held steady by the other hand.*
FDA Label Image

Besremi Figure Y (Besremi 24)

Besremi Figure Y (Besremi 24)
Illustration titled 'Prescription Card' showing a placeholder for a dosage amount in micrograms (mcg) for the BESREMi Pen injection, solution, subcutaneous use by PharmaEssentia USA.*
FDA Label Image

Besremi Figure Z (Besremi 25)

Besremi Figure Z (Besremi 25)
An instructional illustration showing how to hold a syringe vertically and push up slowly to adjust medication to the prescribed dose. The syringe is marked with dosage levels, with an example dose of 350 mcg highlighted. A caution note advises users to adjust the medicine level in the syringe to match their prescribed dose rather than relying on the example shown.*
FDA Label Image

Besremi Figure Aa (Besremi 26)

Besremi Figure Aa (Besremi 26)
An instructional illustration showing a hand pinching the skin, likely demonstrating a subcutaneous injection technique. The figure is labeled 'Figure AA'.*
FDA Label Image

Besremi Figure Ab (Besremi 27)

Besremi Figure Ab (Besremi 27)
An instructional diagram showing the proper subcutaneous injection technique with a syringe held at a 45-degree angle to the skin. The image demonstrates correct injection angle and hand positioning for administration.*
FDA Label Image

Besremi Figure Ac (Besremi 28)

Besremi Figure Ac (Besremi 28)
An instructional illustration showing a hand holding a syringe at an angle, poised to inject into the skin subcutaneously. The image demonstrates the correct injection technique for a subcutaneous injection.*
FDA Label Image

Besremi Figure Ad (Besremi 29)

Besremi Figure Ad (Besremi 29)
An instructional illustration showing the proper technique for using a subcutaneous injection device, with an arrow indicating the direction to insert the needle under the skin.*
FDA Label Image

Besremi Figure Ae (Besremi 30)

Besremi Figure Ae (Besremi 30)
An instructional illustration showing a person removing the cap from the needle of a prefilled pen device for injection. The diagram depicts hands holding the pen and lifting the cap off, with an arrow indicating the direction of removal.*
FDA Label Image

Besremi Figure Af (Besremi 31)

Besremi Figure Af (Besremi 31)
An instructional illustration showing a hand holding a syringe angled downward above a sharps disposal container, demonstrating proper syringe disposal technique by ejecting contents or removing a needle prior to discarding.*
FDA Label Image

Besremi Figure Ag (Besremi 32)

Besremi Figure Ag (Besremi 32)
An instructional illustration showing a hand using a cotton ball to clean or prepare an area of the skin. The image is labeled as Figure AG.*
FDA Label Image

Figure A (Besremi 33)

Figure A (Besremi 33)
Label for BESREMi Pen, containing ropeginterferon alfa-2b, with a strength of 500 mcg/mL in injectable solution form for subcutaneous use. The label includes a dosage scale marking doses from 50 to 500 mcg, a barcode, and packaging information including lot and expiration date fields. Manufactured by PharmaEssentia Corp.*
FDA Label Image

Figure B (Besremi 34)

Figure B (Besremi 34)
Packaging label for BESREMi Pen (ropegnterferon alfa-2b-njft) injection, 500 mcg/mL, a single-dose prefilled syringe for subcutaneous use. The label includes dosage strength, usage warnings, contents such as the syringe and needle, and manufacturer information for PharmaEssentia USA. It also lists inactive ingredients and storage instructions.*
FDA Label Image

Figure C (Besremi 35)

Figure C (Besremi 35)
An instructional illustration showing the BESREMi Pen packaging box and a diagram of the pen device with its parts labeled in a cross-sectional view. The image appears to demonstrate the assembly or use steps for the ROPEGINTERFERON ALFA-2B subcutaneous injection pen by PharmaEssentia USA.*
FDA Label Image

Figure D (Besremi 36)

Figure D (Besremi 36)
An instructional illustration showing a BESREMi Pen packaging box placed on a surface next to a clock indicating a time span of 15 to 30 minutes. This figure likely depicts a waiting or preparation time related to the proper use or storage of the BESREMi Pen injection solution.*
FDA Label Image

Figure E F G (Besremi 37)

Figure E F G (Besremi 37)
Illustration showing items related to injection safety and care: two alcohol swab packets labeled as Figure E, a red sharps disposal container labeled as Figure F, and optional items including a gauze or cotton ball and a small adhesive bandage labeled as Figure G.*
FDA Label Image

Figure H (Besremi 38)

Figure H (Besremi 38)
An instructional illustration labeled Figure H showing a pair of hands being washed under a stream of running water from a faucet. The image depicts proper handwashing technique with soap lather.*
FDA Label Image

Figure I (Besremi 39)

Figure I (Besremi 39)
An instructional illustration showing a box of BESREMi Pen (ROPEGINTERFERON ALFA-2B) injection solution with a focus on the expiration date format, labeled as EXP: YYYY-MM. The image highlights the placement of the expiration date on the product packaging.*
FDA Label Image

Figure J (Besremi 40)

Figure J (Besremi 40)
An instructional illustration showing the BESREMi Pen, a subcutaneous injection device for ROPEGINTERFERON ALFA-2B, alongside a partially open medication box. The image demonstrates the pen being removed from the box to prepare for use.*
FDA Label Image

Figure K (Besremi 41)

Figure K (Besremi 41)
An instructional illustration showing the proper method to connect or assemble parts of the BESREMi Pen injection device. The image depicts a hand holding the pen and aligning its components for use.*
FDA Label Image

Figure L (Besremi 42)

Figure L (Besremi 42)
An instructional illustration showing a BESREMi Pen for subcutaneous injection. The image emphasizes checking the pen for damage before use, indicated by a green checkmark. The pen is shown in profile with a close-up of the injection site near the eye area, labeled as Figure L.*
FDA Label Image

Figure M (Besremi 43)

Figure M (Besremi 43)
An instructional illustration showing a close-up of the BESREMi Pen's injection end with visible liquid medicine inside. It indicates where to check for the liquid medicine before use, with an eye symbol emphasizing visual inspection. The image is labeled 'Figure M'.*
FDA Label Image

Figure N (Besremi 44)

Figure N (Besremi 44)
An anatomical illustration showing recommended subcutaneous injection sites for an injection solution. Highlighted areas include the abdomen around the navel and the upper outer areas of the thighs on both legs.*
FDA Label Image

Figure O (Besremi 45)

Figure O (Besremi 45)
Illustration showing a hand holding a cotton pad or wipe and cleaning or preparing an area of skin, likely for an injection or medical procedure. The image appears instructional for subcutaneous injection preparation.*
FDA Label Image

Figure P (Besremi 46)

Figure P (Besremi 46)
An instructional illustration showing a close-up of hands preparing a prefilled pen device for injection, with focus on removing a cap or cleaning part of the device before use. The image is labeled as Figure P.*
FDA Label Image

Figure Q (Besremi 47)

Figure Q (Besremi 47)
An instructional illustration showing a pair of hands removing or handling a blue strip or tab attached to a small, clear plastic container with a filter or component inside. The image is labeled as Figure Q.*
FDA Label Image

Figure R S (Besremi 48)

Figure R S (Besremi 48)
An instructional illustration showing a two-step process of operating the BESREMi Pen injection device. The first step, labeled 'Push,' shows a hand pressing the pen tip until a "Snap" sound occurs. The second step, labeled 'Turn,' shows the hand rotating the pen tip until a "Click" sound is heard. Both steps involve precise finger movements guiding the pen.*
FDA Label Image

Figure T (Besremi 49)

Figure T (Besremi 49)
An instructional illustration showing a step in using the BESREMi Pen injection device. It depicts a hand pulling off the pen cap from the needle end of the pen, indicated by an arrow and the word 'Pull.' This step is labeled as Figure T.*
FDA Label Image

Symbol (Besremi 50)

Symbol (Besremi 50)
An illustration of a liquid drop with two droplets inside a square frame, likely representing injection or dosage measurement, displayed on a plain background.*
FDA Label Image

Figure U (Besremi 51)

Figure U (Besremi 51)
An instructional diagram showing a close-up of the BESREMi Pen's window, highlighting how a dot next to a drop symbol should align with a notch in the window. The image demonstrates proper alignment technique for the pen's subcutaneous injection.*
FDA Label Image

Figure V (Besremi 52)

Figure V (Besremi 52)
Illustration showing hands holding the BESREMi Pen injection device. The diagram highlights the proper positioning and manipulation of the pen, with an arrow pointing to the bottom end, indicating an operational step in the subcutaneous injection process.*
FDA Label Image

Figure W (Besremi 53)

Figure W (Besremi 53)
An instructional diagram showing a circular green arrow with the text 'Dial 4 Cycles Press' inside, indicating a step in a dosing or injection process. Labeled as 'Figure W,' this image appears to guide the user to dial four cycles and press, likely related to the use of the BESREMi Pen injection device.*
FDA Label Image

Figure X (Besremi 54)

Figure X (Besremi 54)
An instructional illustration showing a syringe needle with a drop of liquid medicine at the tip. The image emphasizes checking for liquid medicine at the needle tip, labeled as Figure X.*
FDA Label Image

Figure Y (Besremi 55)

Figure Y (Besremi 55)
An instructional illustration labeled 'Figure Y' showing a prescription card with the Rx symbol, the text 'Prescription Card,' and a placeholder for a dosage quantity represented as '### mcg.'*
FDA Label Image

Figure Z (Besremi 56)

Figure Z (Besremi 56)
An instructional illustration showing a hand holding a BESREMi Pen injection device. The image zooms in on a labeled dose window on the pen, highlighting the area where the drug dose is displayed. It visually explains the location and importance of the dose window on the injection pen for administering ROPEGINTERFERON ALFA-2B subcutaneously.*
FDA Label Image

Figure Aa (Besremi 57)

Figure Aa (Besremi 57)
Instructional illustration showing a hand holding a BESREMi Pen injection device at a 90-degree angle to the skin surface, demonstrating the proper position for subcutaneous injection of ROPEGINTERFERON ALFA-2B solution.*
FDA Label Image

Figure Ab (Besremi 58)

Figure Ab (Besremi 58)
Instructional diagram showing proper use of the BESREMi Pen injection device. The illustration advises to keep the thumb away from the button while holding the pen, and demonstrates pushing the pen down perpendicularly to insert the needle for subcutaneous injection.*
FDA Label Image

Figure Ac (Besremi 59)

Figure Ac (Besremi 59)
An instructional illustration showing a hand holding a BESREMi Pen injection device vertically while pressing a button down onto a surface, likely skin. The diagram includes a downward arrow emphasizing the button press action for subcutaneous injection administration.*
FDA Label Image

Figure Ad (Besremi 60)

Figure Ad (Besremi 60)
Instructional illustration showing how to use the BESREMi Pen injection device. It depicts a hand holding the pen with the dose window at '0' and the injector needle pressing down on the skin. The image emphasizes holding down the pen for a count of five seconds, with a stopwatch graphic displaying this timing for proper dose administration.*
FDA Label Image

Figure Ae (Besremi 61)

Figure Ae (Besremi 61)
Illustration showing a hand holding a BESREMi Pen, a subcutaneous injection device for ROPEGINTERFERON ALFA-2B injection solution, demonstrating the pen positioned above the skin preparing for injection.*
FDA Label Image

Figure Af (Besremi 62)

Figure Af (Besremi 62)
An instructional illustration showing a hand holding a BESREMi Pen injection device above a disposal container labeled Figure AF, indicating proper disposal of the pen after use.*
FDA Label Image

Figure Ag (Besremi 63)

Figure Ag (Besremi 63)
An instructional illustration showing a hand holding a cotton ball or pad to clean a skin area, likely as a step before a subcutaneous injection. The image is labeled 'Figure AG' at the bottom.*
FDA Label Image

Principal Display Panel (500 mcg/mL Syringe Label)

Principal Display Panel (500 mcg/mL Syringe Label)
Label of BESREMi Pen containing 500 mcg/mL of ropeginterferon alfa-2b solution for subcutaneous injection. The label includes a dosage scale from 50 to 500 mcg, a barcode, and shows the manufacturer as PharmaEssentia Corp. It states Rx Only and provides spaces for lot and expiration information.*
FDA Label Image

Principal Display Panel (500 mcg/mL Syringe Carton)

Principal Display Panel (500 mcg/mL Syringe Carton)
BESREMi Pen injection label for ropeginterferon alfa-2b-njft, 500 mcg/mL strength. The packaging is for a single-dose prefilled syringe for subcutaneous use. The label includes dosing details, contents, cautionary statements, manufacturer PharmaEssentia USA, and storage instructions.*
FDA Label Image

Principal Display Panel (500 mcg/mL Cartridge Label)

Principal Display Panel (500 mcg/mL Cartridge Label)
Label for BESREMi Pen (ropeginterferon alfa-2b-njft) injection, solution, 500 mcg/0.5 mL. It is a single-dose prefilled subcutaneous pen injector produced by PharmaEssentia USA. The label includes storage instructions stating to refrigerate between 36°F to 46°F, protect from light, and keep out of reach of children. The label also shows the National Drug Code (NDC) barcode and marks the product as Rx only.*
FDA Label Image

Principal Display Panel (500 mcg/mL Cartridge Carton)

Principal Display Panel (500 mcg/mL Cartridge Carton)
Packaging label for BESREMi Pen 500 mcg/0.5 mL injection, solution for subcutaneous use. The label features the brand name BESREMi Pen with the generic name ropeginterferon alfa-2b-njft and dosage strength prominently displayed. It includes usage instructions, manufacturer and distributor details (PharmaEssentia Corporation and PharmaEssentia USA), and content information such as single-dose prefilled pen injector and injection needle. The label also displays the NDC 73536-511-01 and contains warnings and medication guide instructions.*
FDA Label Image

Principal Display Panel (500 mcg/mL Cartridge Carton)

Principal Display Panel (500 mcg/mL Cartridge Carton)
Carton packaging label for BESREMi Pen injection, solution, 500 mcg/0.5 mL, containing ropeginterferon alfa-2b. The label features dosing instructions to read before use, a stop sign symbol, a QR code for more information, and a helpline phone number. The label is branded by PharmaEssentia USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.